Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127450931 | 12745093 | 1 | I | 20160620 | 20160915 | 20160915 | PER | US-ASTRAZENECA-2016SE68398 | ASTRAZENECA | 0.00 | M | Y | 113.40000 | KG | 20160915 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127450931 | 12745093 | 1 | SS | METOPROLOL. | METOPROLOL | 1 | Oral | U | 0 | ||||||||||
| 127450931 | 12745093 | 2 | PS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | 21332 | 15 | UG | INJECTION | TID | |||||||
| 127450931 | 12745093 | 3 | SS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | 21332 | 30 | UG | INJECTION | TID | |||||||
| 127450931 | 12745093 | 4 | SS | SYMLIN | PRAMLINTIDE ACETATE | 1 | Subcutaneous | 21332 | 45 | UG | INJECTION | TID | |||||||
| 127450931 | 12745093 | 5 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 127450931 | 12745093 | 6 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | |||||||||||
| 127450931 | 12745093 | 7 | C | AD ASPIRIN | 2 | Oral | 0 | ||||||||||||
| 127450931 | 12745093 | 8 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 127450931 | 12745093 | 9 | C | ONE-A-DAY NOS | MINERALSVITAMINS | 1 | Oral | 0 | |||||||||||
| 127450931 | 12745093 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | |||||||||||
| 127450931 | 12745093 | 11 | C | INSULIN PUMP | INSULIN NOS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127450931 | 12745093 | 2 | Type 1 diabetes mellitus |
| 127450931 | 12745093 | 3 | Type 1 diabetes mellitus |
| 127450931 | 12745093 | 4 | Type 1 diabetes mellitus |
| 127450931 | 12745093 | 5 | Blood cholesterol |
| 127450931 | 12745093 | 7 | Anticoagulant therapy |
| 127450931 | 12745093 | 8 | Blood pressure abnormal |
| 127450931 | 12745093 | 10 | Vitamin D deficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127450931 | 12745093 | Blood cholesterol decreased | |
| 127450931 | 12745093 | Blood glucose fluctuation | |
| 127450931 | 12745093 | Device malfunction | |
| 127450931 | 12745093 | Drug dispensing error | |
| 127450931 | 12745093 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127450931 | 12745093 | 2 | 2014 | 0 |